Table 1 Baseline characteristics of the patients who underwent leadless pacemaker Implantation.
Normal PCT group | Very high PCT group | P-value | |
|---|---|---|---|
(n = 390) | (n = 19) | ||
Age, years | 73.35 ± 16.15 | 73.74 ± 18.64 | 0.778 |
Male sex | 207 (53.08%) | 13 (68.42%) | 0.190 |
BMI | 24.42 ± 17.99 | 23.43 ± 4.47 | 0.827 |
LVEF, % | 66.64 ± 6.49 | 67.39 ± 5.09 | 0.855 |
Comorbidities, n (%) | |||
Hypertension | 223 (57.18%) | 10 (52.63%) | 0.696 |
Diabetes | 116 (29.74%) | 4 (21.05%) | 0.417 |
Coronary artery disease | 108 (27.69%) | 8 (42.11%) | 0.174 |
Dyslipidemia | 52 (13.33%) | 3 (15.79%) | 0.759 |
Atrial fbrillation | 114 (29.23%) | 7 (36.84%) | 0.478 |
Hemodialysis | 12 (3.08%) | 1 (5.26%) | 0.596 |
CKD | 68 (17.44%) | 6 (31.58%) | 0.118 |
Cancer | 7 (1.79%) | 0 (0.00%) | 0.556 |
Stroke | 22 (5.64%) | 2 (10.53%) | 0.376 |
Alzheimer’s disease | 7 (1.80%) | 2 (10.53%) | 0.011 |
COPD | 51 (13.08%) | 6 (31.58%) | 0.023 |
Contraindication for transvenous pacemaker, n (%) | |||
Pacemaker reimplant after pocket infection | 16 (4.10%) | 1 (5.26%) | 0.805 |
Implant indications, n (%) | |||
Atrioventricular block | 237 (60.77%) | 12 (63.16%) | 0.835 |
Sinus node dysfunction | 170 (43.59%) | 7 (36.84%) | 0.562 |
